All Posts Tagged With: "MDT"

(STJ) St. Jude Medical Begins EnligHTNment Study

St. Jude Medical Inc. (STJ) commenced the EnligHTNment trial study at the EuroPCR to analyze the effectiveness of its EnligHTN Multi-Electrode Renal Denervation System in reducing major cardiovascular events such as strokes, heart...

15Sep2013 | | Comments Off | Continued

(LIFE) MedTech Industry Stock Update – May 2013 – Zacks Analyst Interviews

As expected, MedTech mergers and acquisitions (M&A) are heating up in 2013. Finally, the much-hyped takeover battle for Life Technologies Corporation (LIFE) came to an end last month with Thermo Fisher Scientific...

15May2013 | | Comments Off | Continued

(WMT) Earnings Enter the Final Stretch – Earnings Preview

We still have plenty of Q4 earnings reports to come, but the bulk of the earnings season is now behind us, with results from 395 S&P 500 companies already out, as of Friday, February 15. Please note that while these 395 companies account for 86.4% of the index’s total market capitalization and...

19Feb2013 | | Comments Off | Continued

(STJ) St. Jude Medical Begins EnligHTN II Trial

St. Jude Medical Inc. (STJ) has initiated the EnligHTN II trail with the enrolment of first patient to further evaluate its renal denervation technology in treating uncontrolled hypertension. This follows the successful EnligHTN I...

16Feb2013 | | Comments Off | Continued

(WMT) Earnings Enter the Final Stretch – Earnings Preview

We still have plenty of Q4 earnings reports to come, but the bulk of the earnings season is now behind us, with results from 395 S&P 500 companies already out, as of Friday, February 15. Please note that while these 395 companies account for 86.4% of the index’s total market capitalization and...

15Feb2013 | | Comments Off | Continued

(JNJ) MedTech Industry Stock Outlook – January 2013 – Zacks Analyst Interviews

We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide medical devices market. The US still holds the leading position with almost one-third of the market share. However, emerging economies like Brazil, Russia, India and China –...

31Jan2013 | | Comments Off | Continued

(STJ) St. Jude Medical’s Products Earn CE Mark Approval

St. Jude Medical (STJ) has received CE Mark approval for two of its devices viz. the AMPLATZER Amulet Left Atrial Appendage Occluder and the ViewFlex Xtra Intracardiac Echocardiography (ICE) Catheter. Both the products were unveiled...

26Jan2013 | | Comments Off | Continued

(BSX) Boston Scientific Corporation Initiates Ingevity Trial

Boston Scientific Corporation (BSX) recently commenced a trial for its next-generation Ingevity pacing leads. The first patient was implanted to evaluate the safety, effectiveness and ...

27Dec2012 | | Comments Off | Continued

(STJ) St. Jude Medical Wins CE Mark Approval for Assura

Medical devices major, St. Jude Medical (STJ) recently won the European CE Mark approval for its line of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators...

4Dec2012 | | Comments Off | Continued

(STJ) St. Jude Medical Earnings Preview

Medical device major, St. Jude Medical (STJ) is slated to announce its third quarter results before the opening bell on Wednesday, October 17. The current Zacks Consensus Estimate for the third quarter is 80 cents, representing estimated...

31Oct2012 | | Comments Off | Continued

(IART) Integra LifeSciences Holdings Corporation Exhibits Neuro Product Line

Medical products company, Integra LifeSciences Holdings Corporation (IART) is demonstrating its MAYFIELD Composite Series Cranial Stabilization product line at the Congress of Neurological Surgeons (“CNS”) annual meet...

10Oct2012 | | Comments Off | Continued

(STJ) St. Jude Medical Reports Positive Data

Medical devices major, St. Jude Medical, Inc. (STJ) recently announced results from a large-scale clinical study of peripheral nerve stimulus (PNS) of the occipital nerve for managing pain and disability associated with chronic migraine,...

8Oct2012 | | Comments Off | Continued

(SNN) MedTech Industry Stock Outlook – October 2012 – Zacks Analyst Interviews

The global medical devices industry is fairly large, intensely competitive and highly innovative. A regulated industry, MedTech is spread across different segments including cardiology, cardiovascular, neuro, orthopedic and aesthetic devices. The US medical devices industry relies largely on an aging...

4Oct2012 | | Comments Off | Continued

(STJ) St. Jude Medical Realigns Units – Cuts Jobs

Medical devices major, St. Jude Medical, Inc. (STJ) recently announced that it will consolidate its four operating segments into two units as a part of its cost-cutting measure to leverage future growth. The company also changed the...

18Sep2012 | | Comments Off | Continued

(ALNY) Alnylam Pharmaceuticals and Monsanto Collaborate

Alnylam Pharmaceuticals, Inc. (ALNY) and Monsanto Company (MON) recently formed a strategic alliance to implement biological technologies in the field of agriculture....

30Aug2012 | | Comments Off | Continued

(GB) Greatbatch’s Second Quarter Earnings Mixed – Profit Drops

Greatbatch, Inc. (GB) reported second-quarter 2012 adjusted (excluding one-time items) earnings per share of 43 cents, in line with both the Zacks Consensus Estimate and the year-ago adjusted earnings. Profits (as reported) plunged...

22Aug2012 | | Comments Off | Continued

(ALNY) Alnylam Pharmaceuticals Earns Milestone Payment

Alnylam Pharmaceuticals Inc. (ALNY) recently earned development milestone payment of $3.2 million from GlaxoSmithKline (GSK). The payment was earned due to the progress...

21Aug2012 | | Comments Off | Continued

(MDT) Medtronic Meets Earnings Forecasts

Medtronic Inc. (MDT) reported first quarter fiscal 2013 earnings per share of 83 cents, up 8% year over year. After taking into account certain one-time items, the adjusted EPS was 85 cents, also up 8% year over year and in...

21Aug2012 | | Comments Off | Continued

(STJ) St. Jude Medical Beats by a Penny – Trims Outlook

Medical devices major, St. Jude Medical, Inc.’s (STJ) second quarter 2012 adjusted earnings of 88 cents per share beat the Zacks Consensus Estimate by a penny and surpassed the year-ago earnings of 85 cents per share. Earnings were...

13Aug2012 | | Comments Off | Continued

(GB) Greatbatch to Build Research and Development Center

Medical technologies company, Greatbatch Inc. (GB) recently announced that it will set up an Active Implantable Medical Device (“AIMD”) Research and Development (“R&D”) Centre in Singapore. It will be Greatbatch’s first...

23Jul2012 | | Comments Off | Continued

(MDT) Medtronic Hikes Dividend

Leading medical device player, Medtronic (MDT) announced a 7.2% increase in its cash dividend for fiscal 2013. With this hike, the dividend for the quarter comes to 26 cents per share or $1.04 per share for fiscal 2013, up from 97...

26Jun2012 | | Comments Off | Continued

(JNJ) MedTech Stock Outlook – June 2012 – Industry Outlook

Over the recent past, medical technology (MedTech) players have faced the brunt of exigent economic conditions and a precarious healthcare environment. The performance of the players was thereby hamstrung by several macro issues, including sustained price erosion and procedure volume pressures. The...

16Jun2012 | | Comments Off | Continued

(MDT) Medtronic Posts Mixed Numbers

Medtronic Inc. (MDT) reported fourth quarter fiscal 2012 earnings per share (EPS) of 94 cents, up 31% year over year. However, adjusted EPS during the quarter came in at 99 cents, 10% above the year-ago period...

28May2012 | | Comments Off | Continued

(STJ) St. Jude Medical Build on Alliance with Abbott Laboratories

St. Jude Medical Inc. (STJ) recently disclosed its decision to build on its mutual agreement with Abbott Laboratories (ABT) by revealing the long-term Choice Alliance...

28Apr2012 | | Comments Off | Continued

(IART) Integra LifeScience Holdings Corporation Earns FDA Nod for Spine Device

Global provider of surgical implants and medical instruments, Integra LifeScience Holdings Corporation (IART) recently received the 510(k) clearance from the US Food and Drug Administration (FDA) for its path-breaking...

23Apr2012 | | Comments Off | Continued

(STJ) St. Jude Beats The Street – Raises Guidance

St. Jude Medical, Inc. (STJ), a large-cap medical devices and technology development company, reported first quarter fiscal 2012 adjusted earnings of 86 cents beating the Zacks Consensus Estimate of 83 cents per share and surpassing...

20Apr2012 | | Comments Off | Continued

(MDT) MedTech Industry Stock Outlook – March 2012 – Zacks Analyst Interviews

Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The...

19Mar2012 | | Comments Off | Continued

(MDT) MedTech Industry Stock Outlook – March 2012 – Industry Outlook

Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The...

8Mar2012 | | Comments Off | Continued

(GB) Greatbatch Buying NeuroNexus

Medical technology company Greatbatch (GB) is acquiring Michigan-based implantable medical device design firm NeuroNexus Technologies for roughly $12 million. The deal includes assumption of debt and future considerations (undisclosed). NeuroNexus,...

23Feb2012 | | 0 comments | Continued

(STJ) St. Jude Medical Fourth Quarter 2011 Earnings Scorecard

Medical devices major St. Jude Medical’s (STJ) fourth-quarter 2011 adjusted earnings per share of 86 cents beat the Zacks Consensus Estimate by a couple of cents and exceeded the year-ago earnings of 75 cents. Highlights...

6Feb2012 | | 0 comments | Continued